A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/medtech/abbott-replace-certain-freestyle-libre-3-cgms-after-incorrect-readings-and-death-reports" hreflang="en">Abbott to replace certain FreeStyle Libre 3 CGMs after incorrect readings and death reports</a>
A manufacturing defect on a single production line may have affected about 3 million FreeStyle Libre 3 and Libre 3 Plus sensors in the U.S.
Agilent (A) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Agilent (A) Reports Q4 Earnings: What Key Metrics Have to Say Yahoo Finance
Top Stock Reports for Alphabet, Roche & RTX - Nasdaq
Top Stock Reports for Alphabet, Roche & RTX Nasdaq
Agilent Technologies Reports Fourth-Quarter Fiscal Year 2025 Financial Results - TradingView
Agilent Technologies Reports Fourth-Quarter Fiscal Year 2025 Financial Results TradingView
Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results - Bakersfield.com
Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results Bakersfield.com
Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results - Business Wire
Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results Business Wire
Sarepta to pay $200M milestone to Arrowhead; Enlivex reports osteoarthritis data
Plus, news about Clearside Biomedical, Pfizer, Astellas, Merck, MindImmune Therapeutics and Poxel: 💵 Sarepta to pay Arrowhead $200M as it continues type 1 myotonic dys...
Why Agilent Technologies Inc. stock stays resilient - Stop Loss & Daily Stock Momentum Reports - newser.com
Why Agilent Technologies Inc. stock stays resilient - Stop Loss & Daily Stock Momentum Reports newser.com
How Waters Corporation stock benefits from strong dollar - 2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com
How Waters Corporation stock benefits from strong dollar - 2025 Bull vs Bear & Smart Allocation Stock Reports newser.com
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed Fierce Biotech
10x Genomics Reports Third Quarter 2025 Financial Results - Barchart.com
10x Genomics Reports Third Quarter 2025 Financial Results Barchart.com
10x Genomics Reports Third Quarter 2025 Financial Results - Eastern Progress
10x Genomics Reports Third Quarter 2025 Financial Results Eastern Progress
10x Genomics Reports Third Quarter 2025 Financial Results - PR Newswire
10x Genomics Reports Third Quarter 2025 Financial Results PR Newswire
Waters Corporation Reports Strong Q3 2025 Results - TipRanks
Waters Corporation Reports Strong Q3 2025 Results TipRanks
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 - PR Newswire
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 PR Newswire